Progestogens reduce thromboxane production by cultured human endothelial cells

Climacteric

Volumn 14, Issue 1, 2011, Pages 41-48

  Oviedo, P J ^a   Sobrino, A ^a   Novella, S ^a,b   Rius, C ^b   Laguna Fernandez, A ^a   Garcia Perez M A ^a   Tarin J J ^b   Cano, A ^b   Hermenegildo, C ^a,b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

endothelium; progestogens; prostaglandins; Thromboxane

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; CYCLOOXYGENASE 2 INHIBITOR; MEDROXYPROGESTERONE ACETATE; MIFEPRISTONE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROGESTERONE; PROGESTERONE RECEPTOR; PROSTACYCLIN; PROSTACYCLIN SYNTHASE; THROMBOXANE A2; THROMBOXANE B2; THROMBOXANE SYNTHASE;

ARTICLE; CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, HORMONAL; BLOTTING, WESTERN; CELLS, CULTURED; CYCLOOXYGENASE INHIBITORS; CYTOCHROME P-450 ENZYME SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; GENE EXPRESSION; HORMONE ANTAGONISTS; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MEDROXYPROGESTERONE ACETATE; MIFEPRISTONE; POLYMERASE CHAIN REACTION; PROGESTERONE; PROGESTINS; PYRAZOLES; RNA, MESSENGER; THROMBOXANE A2; THROMBOXANE B2; THROMBOXANE-A SYNTHASE; UMBILICAL VEINS;

EID: 79951613248     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697131003602496     Document Type: Article

References (37)

1. Schumacher M, Guennoun R, Ghoumari A, et al. Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system. Endocr Rev 2007;28:387-439 (Pubitemid 46984826)
2. Simoncini T, Mannella P, Fornari L, Caruso A, Varone G, Genazzani AR. In vitro effects of progesterone and progestins on vascular cells. Steroids 2003;68:831-6 (Pubitemid 37532407)
3. Hermenegildo C, Oviedo PJ, Garcia-Martinez MC, Garcia-Perez MA, Tarin JJ, Cano A. Progestogens stimulate prostacyclin production by human endothelial cells. Hum Reprod 2005;20:1554-61 (Pubitemid 40852247)
4. Vazquez F, Rodriguez-Manzaneque JC, Lydon JP, Edwards DP, O'Malley BW, Iruela-Arispe ML. Progesterone regulates proliferation of endothelial cells. J Biol Chem 1999;274:2185-92
5. Welter BH, Hansen EL, Saner KJ, Wei Y, Price TM. Membranebound progesterone receptor expression in human aortic endothelial cells. J Histochem Cytochem 2003;51:1049-55 (Pubitemid 36919982)
6. Selles J, Polini N, Alvarez C, Massheimer V. Nongenomic action of progesterone in rat aorta: role of nitric oxide and prostaglandins. Cell Signal 2002;14:431-6 (Pubitemid 34214847)
7. Sorensen KE, Dorup I, Hermann AP, Mosekilde L. Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function. Circulation 1998;97:1234-8 (Pubitemid 28169174)
8. Karas RH, van Eickels M, Lydon JP, et al. A complex role for the progesterone receptor in the response to vascular injury. J Clin Invest 2001;108:611-18 (Pubitemid 32777741)
9. Koh KK, Jin DK, Yang SH, et al. Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women. Circulation 2001;103:1961-6 (Pubitemid 32322223)
10. Chataigneau T, Zerr M, Chataigneau M, et al. Chronic treatment with progesterone but not medroxyprogesterone acetate restores the endothelial control of vascular tone in the mesenteric artery of ovariectomized rats. Menopause 2004;11:255-63 (Pubitemid 40362179)
11. Simoncini T, Mannella P, Fornari L, et al. Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells. Endocrinology 2004;145:5745-6
12. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115-26
13. Oliveira RL, Aldrighi JM, Gebara OE, et al. Postmenopausal hormone replacement therapy increases plasmatic thromboxane [beta]2. Int J Cardiol 2005;99:449-54 (Pubitemid 40363997)
14. Vane JR. Back to an aspirin a day? Science 2002;296:474-5
15. Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 2000;69:145-82
16. Linton MF, Fazio S. Cyclooxygenase-2 and atherosclerosis. Curr Opin Lipidol 2002;13:497-504 (Pubitemid 35231929)
17. Hermenegildo C, Oviedo PJ, Cano A. Cyclooxygenases regulation by estradiol on endothelium. Curr Pharm Des 2006;12:205-15
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;196:265-75
19. Oviedo PJ, Hermenegildo C, Cano A. Raloxifene increases the capacity of serum to promote prostacyclin release in human endothelial cells: implication of COX-1 and COX-2. Menopause 2004;11:430-7 (Pubitemid 40362167)
20. Witter FR, DiBlasi MC. Effect of steroid hormones on arachidonic acid metabolites of endothelial cells. Obstet Gynecol 1984;63:747-51 (Pubitemid 14143932)
21. Berge LN, Hansen JB, Svensson B, Lyngmo V, Nordoy A. Female sex hormones and platelet/endothelial cell interactions. Haemostasis 1990;20:313-20
22. Persico N, Mancini F, Artini PG, et al. Transdermal HRT and Doppler findings in normotensive and hypertensive postmenopausal patients. Ultrasound Obstet Gynecol 2005;26:546-51 (Pubitemid 41634542)
23. Giangrande PH, Kimbrel A, Edwards DP, McDonnell DP. The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding. Mol Cell Biol 2000;20:3102-15 (Pubitemid 30215023)
24. Tatsumi H, Kitawaki J, Tanaka K, Hosoda T, Honjo H. Lack of stimulatory effect of dienogest on the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by endothelial cell as compared with other synthetic progestins. Maturitas 2002;42:287-94 (Pubitemid 35007322)
25. Toth B, Saadat G, Geller A, et al. Human umbilical vascular endothelial cells express estrogen receptor beta (ERb) and progesterone receptor A (PR-A), but not ERa and PR-B. Histochem Cell Biol 2008;130:399-405
26. Mikkola T, Ranta V, Orpana A, Ylikorkala O, Viinikka L. Effect of physiological concentrations of estradiol on PGI2 and NO in endothelial cells. Maturitas 1996;25:141-7 (Pubitemid 26336679)
27. Akarasereenont P, Techatraisak K, Thaworn A, Chotewuttakorn S. The induction of cyclooxygenase-2 by 17beta-estradiol in endothelial cells is mediated through protein kinase C. Inflamm Res 2000;49:460-5
28. Parente L, Perretti M. Advances in the pathophysiology of constitutive and inducible cyclooxygenases: two enzymes in the spotlight. Biochem Pharmacol 2003;65:153-9 (Pubitemid 36015818)
29. Hermenegildo C, Oviedo PJ, Garcia-Perez MA, Tarin JJ, Cano A. Effects of phytoestrogens genistein and daidzein on prostacyclin production by human endothelial cells. J Pharmacol Exp Ther 2005;315:722-8 (Pubitemid 41500738)
30. Ueno N, Murakami M, Tanioka T, et al. Coupling between cyclooxygenase, terminal prostanoid synthase, and phospholipase A2. J Biol Chem 2001;276:34918-27
31. Garcia-Redondo AB, Briones AM, Beltran AE, Alonso MJ, Simonsen U, Salaices M. Hypertension increases contractile responses to hydrogen peroxide in resistance arteries through increased thromboxane A2, Ca2+, and superoxide anion levels. J Pharmacol Exp Ther 2009;328:19-27
32. Foudi N, Louedec L, Cachina T, Brink C, Norel X. Selective cyclooxygenase-2 inhibition directly increases human vascular reactivity to norepinephrine during acute inflammation. Cardiovasc Res 2009;81:269-77
33. Li M, Kuo L, Stallone JN. Estrogen potentiates constrictor prostanoid function in female rat aorta by upregulation of cyclooxygenase-2 and thromboxane pathway expression. AJP-Heart Circ Physiol 2008;294: H2444-55
34. Sellers MM, Stallone JN. Sympathy for the devil: the role of thromboxane in the regulation of vascular tone and blood pressure. AJP-Heart Circ Physiol 2008;294: H1978-86
35. Badimon L, Bayes-Genis A. Effects of progestogens on thrombosis and atherosclerosis. Hum Reprod Update 1999;5:191-9 (Pubitemid 29271955)
36. Lewis GD, Campbell WB, Johnson AR. Inhibition of prostaglandin synthesis by glucocorticoids in human endothelial cells. Endocrinology 1986;119:62-9 (Pubitemid 16100708)
37. Mueck AO, Seeger H, Wallwiener D. Medroxyprogesterone acetate versus norethisterone: effect on estradiol-induced changes of markers for endothelial function and atherosclerotic plaque characteristics in human female coronary endothelial cell cultures. Menopause 2002;9:273-81 (Pubitemid 34743452)